What type of doctor manages a patient with pulmonary hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pulmonary Hypertension: Specialist Referral

Patients with pulmonary hypertension should be managed by a multidisciplinary team at a specialized pulmonary hypertension center that includes both cardiologists and pulmonologists, not by a single pulmonologist or cardiologist alone. 1, 2

Why Specialized Centers Are Essential

Pulmonary hypertension is a rare, complex disease with high mortality that requires expertise beyond what a single specialist can provide. 1 The management involves:

  • Multidisciplinary team composition that must include at minimum two consultant physicians (from cardiology and/or respiratory medicine) with dedicated PH expertise, clinical nurse specialists, radiologists with PH imaging expertise, and physicians skilled in echocardiography and right heart catheterization. 1, 2

  • Access to comprehensive diagnostic capabilities including right heart catheterization laboratories, advanced imaging (CT, MRI, nuclear scanning), exercise testing, and vasoreactivity testing facilities. 1

  • Established networks with other essential services including genetics, connective tissue disease specialists, pulmonary endarterectomy surgeons, lung transplantation programs, and adult congenital heart disease specialists. 1, 2

Characteristics of Qualified PH Centers

A legitimate pulmonary hypertension referral center should meet these criteria:

  • Volume requirements: Follow at least 50 patients with PAH or CTEPH and receive at least 2 new referrals per month with documented disease. 1, 2

  • Technical expertise: Perform at least 20 vasoreactivity tests annually in appropriate PAH patients. 1, 2

  • Access to all approved therapies available in the country, including intravenous prostacyclin therapy and other advanced treatments. 1

  • Participation in clinical research including phase II and III clinical trials to advance treatment options. 1

When to Refer

All patients with suspected or confirmed pulmonary arterial hypertension (Group 1 PH) or chronic thromboembolic pulmonary hypertension (Group 4 CTEPH) must be referred to a specialized center. 2, 3, 4

  • Immediate referral is critical because treatment approaches differ fundamentally based on PH classification, and inappropriate therapy can cause harm. 5

  • Early telephone consultation between local physicians and PH specialists should occur promptly, with plans for in-person evaluation as soon as possible. 5

Common Pitfalls to Avoid

  • Do not attempt solo management: Even experienced cardiologists or pulmonologists should not manage PH patients alone outside of a specialized center, as the complexity requires multidisciplinary expertise. 1, 2, 6

  • Do not delay referral: Attempting to complete the entire workup locally without specialist input often results in incomplete evaluation and inappropriate therapy initiation. 5

  • Recognize the risk of therapy interruption: Abrupt discontinuation of prostanoid therapy can lead to rebound pulmonary hypertension and clinical deterioration, emphasizing the need for centers with 24/7 expertise. 2

Collaborative Care Model

While specialized centers provide definitive management, family physicians and general cardiologists maintain an important role in:

  • Managing comorbidities that contribute to PH, particularly in Group 2 (left heart disease) and Group 3 (lung disease) PH where no directed therapies exist. 7

  • Providing supportive care including immunizations, contraception counseling, preoperative assessment, and mental health support in coordination with the PH center. 7

  • Regular monitoring with follow-up assessments every 3-6 months in stable patients, coordinated with the specialized center. 2, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Pulmonary Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pulmonary Hypertension: A Brief Guide for Clinicians.

Mayo Clinic proceedings, 2020

Guideline

Initial Management of Pulmonary Hypertension When Type is Unknown

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pulmonary Hypertension: Diagnosis and Treatment.

American family physician, 2016

Guideline

Initial Approach to Pulmonary Arterial Hypertension (PAH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.